A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an NCI U01 grant on New Approaches to Synthetic Lethality for Mutant KRas-Dependent Cancers. Their team, which also includes Drs. Ben Major at UNC, Kris Wood … Continue reading Cox and Der lead team to $2M+ NCI U01 grant
Please join us Tuesday, June 16, 2015 12:00 pm PDT (San Francisco) / 3:00 pm EST Channing will be presenting a webinar entitled "Killing KRAS: The Key to a Pancreatic Cancer Treatment Breakthrough?" He will discuss the most common genetic mutation found in pancreatic tumors. It will focus on research aimed at understanding KRAS in pancreatic … Continue reading PanCAN Webinar June 16 > Killing KRAS: The Key to a Pancreatic Cancer Treatment Breakthrough?
Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill. The 2014 Innovation Award winners are: Paul Armistead, MD, PhD, assistant professor in the UNC School of Medicine - "Microwell based Selection and Expansion … Continue reading Kent Rossman is a 2014 University Cancer Research Fund Innovation Award Winner
Congrats to Tikvah Hayes, honored with 2014 Minority Scholar in Cancer Research Award by @AACR! She's presenting research @ #AACR14 today April 8, 2014. Tikvah K. Hayes, B.A., Univ. of North Carolina, Chapel Hill, Chapel Hill, NC “Currently, my research goals entail expanding my knowledge in the field of cancer biology, diversifying my experimental technique, … Continue reading Tikvah Hayes Honored with AACR 2014 Minority Scholar in Cancer Research Award